Cambridge Investment Research Advisors Inc. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) by 10.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,569 shares of the company's stock after purchasing an additional 2,938 shares during the quarter. Cambridge Investment Research Advisors Inc.'s holdings in Cardinal Health were worth $1,650,000 as of its most recent filing with the SEC.
Several other large investors have also recently made changes to their positions in CAH. Blair William & Co. IL increased its position in shares of Cardinal Health by 6.4% during the fourth quarter. Blair William & Co. IL now owns 11,035 shares of the company's stock worth $568,000 after purchasing an additional 664 shares in the last quarter. LPL Financial LLC grew its holdings in Cardinal Health by 2.5% in the 4th quarter. LPL Financial LLC now owns 87,030 shares of the company's stock valued at $4,481,000 after buying an additional 2,105 shares in the last quarter. Alliancebernstein L.P. grew its holdings in Cardinal Health by 1.6% in the 4th quarter. Alliancebernstein L.P. now owns 505,232 shares of the company's stock valued at $26,014,000 after buying an additional 7,954 shares in the last quarter. Lombard Odier Asset Management Switzerland SA purchased a new stake in Cardinal Health in the 4th quarter valued at $503,000. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in Cardinal Health by 89.6% in the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 13,734 shares of the company's stock valued at $707,000 after buying an additional 6,490 shares in the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
Get Cardinal Health alerts:Cardinal Health Price Performance
CAH opened at $66.68 on Friday. The stock's 50-day moving average price is $66.33 and its 200 day moving average price is $59.89. Cardinal Health, Inc. has a 12-month low of $45.85 and a 12-month high of $72.28. The company has a current ratio of 1.08, a quick ratio of 0.57 and a debt-to-equity ratio of 5.33. The firm has a market cap of $17.47 billion, a price-to-earnings ratio of 10.01, a PEG ratio of 1.52 and a beta of 0.77.
Cardinal Health (NYSE:CAH – Get Rating) last posted its earnings results on Thursday, August 11th. The company reported $1.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.17 by ($0.12). Cardinal Health had a positive return on equity of 568.57% and a negative net margin of 0.51%. The firm had revenue of $47.10 billion for the quarter, compared to analyst estimates of $44.82 billion. During the same period in the previous year, the company posted $0.77 EPS. Cardinal Health's revenue was up 10.6% on a year-over-year basis. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 5.25 earnings per share for the current year.Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Saturday, October 15th. Investors of record on Monday, October 3rd will be paid a dividend of $0.4957 per share. This represents a $1.98 annualized dividend and a yield of 2.97%. The ex-dividend date of this dividend is Friday, September 30th. Cardinal Health's payout ratio is 29.73%.
Analysts Set New Price Targets
Several analysts have issued reports on CAH shares. UBS Group upped their target price on Cardinal Health from $61.00 to $78.00 and gave the company a "buy" rating in a report on Monday, August 29th. StockNews.com upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Friday, August 12th. Barclays upped their target price on Cardinal Health to $67.00 in a report on Monday, August 15th. Cowen upped their price target on Cardinal Health from $59.00 to $72.00 and gave the company a "market perform" rating in a research note on Tuesday, August 16th. Finally, Cowen upped their price target on Cardinal Health from $59.00 to $72.00 and gave the company a "market perform" rating in a research note on Tuesday, August 16th. Seven analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has an average rating of "Hold" and a consensus target price of $70.20.
Cardinal Health Profile
(Get Rating)
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Get a free copy of the StockNews.com research report on Cardinal Health (CAH)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Get Rating).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.